A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Running, not enrolling

Conditions studied: Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria

In brief

TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.

Key facts

Study ID

NCT03661866

Run by

Target PharmaSolutions, Inc.

People needed

15000

Starts

2018-12-21

Expected to finish

2050-12-01

Last updated by the study team

2026-03-20

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 1. Adults and children (all ages) with Atopic Dermatitis or other Immune-mediated Inflammatory Skin Conditions been prescribed any dermatologic treatment.
• 2. Participant has plans for future visits at the site for continued management of IMISC.

You may not qualify if…

• 1. Inability to provide written informed consent/assent.
• 2. Subjects participating in any interventional study or trial for IMISC treatment trial at the time of enrollment. Patients may be enrolled in TARGET-DERM once participation in the trial is complete. Note: Participants may be enrolled in other registries or studies where IMISC treatment outcomes are observed and/or reported (such as center-based registries).

Where it is running

• Johnson Dermatology — Fort Smith, Arkansas, United States
• University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
• Arkansas Dermatology — Little Rock, Arkansas, United States
• First OC Dermatology — Fountain Valley, California, United States
• Center for Dermatology Cosmetic and Laser Surgery — Fremont, California, United States
• University of California — Irvine, California, United States
• University of California - San Diego/Rady Children's Hospital — San Diego, California, United States
• George Washington University — Washington D.C., District of Columbia, United States
• Feinstein Dermatology and Cosmetic Surgery — Hollywood, Florida, United States
• Academic Alliance in Dermatology — Tampa, Florida, United States
• Integrated Dermatology of West Palm Beach — West Palm Beach, Florida, United States
• Lurie Children's Hospital/Northwestern University — Chicago, Illinois, United States
• Dawes Fretzin Dermatology/ Dawes Fretzin Clinical Research Group — Indianapolis, Indiana, United States
• The University of Kansas Medical Center — Kansas City, Kansas, United States
• Family Allergy and Asthma Research Institute — Louisville, Kentucky, United States
• DermAssociates, LCC — Rockville, Maryland, United States
• Integrated Dermatology of Massachusetts — Quincy, Massachusetts, United States
• University of Massachusetts Medical School — Worcester, Massachusetts, United States
• University of Minnesota — Minneapolis, Minnesota, United States
• Mayo Clinic — Rochester, Minnesota, United States
• Carl Thornblade, MD, PLLC — Missoula, Montana, United States
• South Lincoln Dermatology Clinic — Lincoln, Nebraska, United States
• Advanced Dermatology of the Midlands — Omaha, Nebraska, United States
• Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States
• Clear Dermatology & Aesthetics Center/Investigative MD — Scottsdale, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.